Breast cancer guidelines

This webpage covers NICE guidelines on breast cancer. The table below presents the guidelines alphabetically with links to the surveillance report where relevant. Updates planned or in progress and areas being actively monitored are listed for each guideline and there are links to the individual update pages for more information.

Guidelines

Guideline	Updates planned or in progress	Areas we’re actively monitoring
Advanced breast cancer: diagnosis and treatment (CG81)	Updates in progress Lymphoedema in all people with breast cancer (see also early and locally advanced breast cancer) Chemotherapy for advanced breast cancer Biological therapy for advanced breast cancer Ovarian function suppression for premenopausal and perimenopausal women with oestrogen receptor-positive early, locally advanced and advanced breast cancer  (see also early and locally advanced breast cancer) Updates planned Menopausal symptoms in all people with breast cancer (see also early and locally advanced breast cancer)	Chemotherapy for advanced breast cancer Endocrine therapy for advanced breast cancer Biological therapy for advanced breast cancer
Early and locally advanced breast cancer: diagnosis and management (NG101)	Updates in progress Further breast surgery after breast-conserving surgery based on tissue margins Neoadjuvant chemotherapy for people with HER2-positive invasive breast cancer and triple-negative invasive breast cancer (early and locally advanced breast cancer) Lymphoedema in all people with breast cancer (see also advanced breast cancer) Platinum-based neoadjuvant chemotherapy regimens for people with triple-negative invasive early and locally advanced breast cancer Ovarian function suppression for premenopausal and perimenopausal women with oestrogen receptor-positive early, locally advanced and advanced breast cancer (see also advanced breast cancer) Updates planned Genetic testing for people with early and locally advanced breast cancer Menopausal symptoms in all people with breast cancer (see also advanced breast cancer) Psychological support for all people with breast cancer	Surgery to the breast Surgery to the axilla Endocrine therapy Neoadjuvant endocrine therapy Adjuvant chemotherapy for early and locally advanced breast cancer Neoadjuvant chemotherapy for early and locally advanced breast cancer Biological therapy for early and locally advanced breast cancer Radiotherapy after breast-conserving surgery Radiotherapy after mastectomy Dose fractionation for external beam radiotherapy
Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (CG164)	Updates planned Genetic testing for people with early and locally advanced breast cancer	-

Methods

Areas for active monitoring are identified by our maintaining and updating our guideline portfolio process including validation with stakeholders.

Active monitoring is ongoing surveillance in key topic areas. It involves one or more of:

• monitoring studies in progress by systematically searching for ongoing studies and assessing the results when published
• monitoring newly published studies by continuous searching of newly published evidence
• system monitoring by systematically collating intelligence from the health and care system and working with partners to identify areas of change.

Guideline recommendations are developed using the methods and processes in developing NICE guidelines: the manual and the interim principles for methods and processes for supporting digital living guideline recommendations.

If you have new information, intelligence or evidence relevant to any of the key topic areas listed above, please contact prioritisation@nice.org.uk.